摘要:
A medicinal composition comprising an oligonucleotide delivery complex formed from an immunostimulatory oligonucleotide containing at least one unmethylated CpG dinucleotide and a sterol, a lipid, or a target cell specific binding agent. The oligonucleotide can be stabilised or a phosphodiester.
摘要:
Immunostimulatory phosphodiester oligonucleotides, which contain at least one unmethylated CpG dinucleotide, do not contain a six base palindrome and include more than eight, but no more than 100 nucleotides, for medicinal use.
摘要:
The present invention is based on the finding that nucleic acids containing at least one unmethylated cytosine-guanine (CpG) dinucleotide affect immune responses in a subject. These nucleic acids containing at least one unmethylated cytosine-guanine (CpG) dinucleotide can be used to induce an immune response in a subject. The method includes administering to the subject a therapeutically effective amount of nucleic acid encoding an antigenic polypeptide, and a therapeutically effective amount of an oligonucleotide containing at least one unmethylated CpG dinucleotide. The invention also provides a method for treating a subject having or at risk of having viral-mediated disorder, comprising administering to the subject a therapeutically effective amount of a nucleic acid encoding an antigenic polypeptide and an effective amount of an oligonucleotide containing at least one unmethylated CpG dinucleotide
摘要:
The present invention is based on the finding that nucleic acids containing at least one unmethylated cytosine-guanine (CpG) dinucleotide affect immune responses in a subject. These nucleic acids containing at least one unmethylated cytosine-guanine (CpG) dinucleotide can be used to induce an immune response in a subject. The method includes administering to the subject a therapeutically effective amount of nucleic acid encoding an antigenic polypeptide, and a therapeutically effective amount of an oligonucleotide containing at least one unmethylated CpG dinucleotide. The invention also provides a method for treating a subject having or at risk of having viral-mediated disorder, comprising administering to the subject a therapeutically effective amount of a nucleic acid encoding an antigenic polypeptide and an effective amount of an oligonucleotide containing at least one unmethylated CpG dinucleotide
摘要:
Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation are disclosed. The sequences are also useful as synthetic adjuvant.
摘要:
Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation are disclosed. The sequences are also useful as synthetic adjuvant.
摘要:
An isolated immunostimulatory oligonucleotide comprising two or more unmethylated CpG dinucleotides, and having a sequence including the following formula:
5'N 1 X 1 X 2 CGTTN 2 3'
wherein the immunostimulatory oligonucleotide includes a modified backbone, at least one nucleotide separates consecutive CpGs, X 1 X 2 is GpT or ApT, N 1 is any nucleotide that includes a 5' TC or TG, N 1 + N 2 is from 0-26 bases, and the immunostimulatory oligonucleotide is from 8-30 bases in length and begins with TC or TG at the 5' end, with the proviso that neither N 1 nor N 2 contains a CCGG quadmer or more than one CCG or CGG trimer.
摘要翻译:包含两个或更多个未甲基化的CpG二核苷酸的分离的免疫刺激性寡核苷酸,并且具有包括下式的序列:ƒ€ƒ€ƒ€ƒ€ƒ€ƒ5'N1 X 1 X 2 CGTTN 2 3'其中 免疫刺激性寡核苷酸包括修饰的主链,至少一个核苷酸分离连续的CpG,X 1 X 2是GpT或ApT,N 1是包括5'TC或TG的任何核苷酸,N 1 + N 2是0-26个碱基, 免疫刺激寡核苷酸长度为8-30个碱基,以5'末端的TC或TG开始,条件是N 1和N 2均不含有CCGG四聚体或多于一个CCG或CGG三聚体。